NSCLC, adding nivolumab to tivozanib in metastatic RCC underwhelms, and T-DXd shows improvement in HER2+ breast cancer with brain metastases.
Researchers have identified thousands of genetic variants in a gene that could raise an individual's risk of ovarian and ...
Researchers have identified thousands of genetic variants in a gene that could raise an individual's risk of ovarian and ...
This 'cancer protection' gene could actually raise your risk of breast and ovarian cancer—here’s what you need to know ...